Dramatic response of cutaneous, nail, and joint symptoms of psoriasis to apremilast
Apremilast has been available in India for the past 6 months as a therapy for psoriasis. A 31-year-old male patient with a diagnosis of psoriasis with oligoarthritis who was not tolerating methotrexate was treated with apremilast. We noticed a dramatic response to the cutaneous and joint symptom wit...
Main Authors: | Meghana Bathina, Amina Asfiya Iqbal, Malcolm Pinto, Manjunath M Shenoy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Clinical Dermatology Review |
Subjects: | |
Online Access: | http://www.cdriadvlkn.org/article.asp?issn=2542-551X;year=2019;volume=3;issue=1;spage=106;epage=108;aulast=Bathina |
Similar Items
-
Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016-09-01) -
Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis
by: Yu. L. Korsakova, et al.
Published: (2018-07-01) -
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
by: Gisondi P, et al.
Published: (2016-05-01) -
Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study
by: Giovanna Malara, et al.
Published: (2021-09-01) -
Apremilast in psoriasis and beyond: Big hopes on a small molecule
by: T P Afra, et al.
Published: (2019-01-01)